Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial of Its Lead Drug Candidate VRG50635
Discover how Verge Genomics is using AI to track speech changes in ALS patients during clinical trials, making data collection easier and more accurate for e...